Novartis: Diovan spreads its wings

home   >   MSN news

Novartis's antihypertensive Diovan has shown promising results in lowering cardiovascular risk.New results from the VALUE trial have shown that Diovan lowered the risk of developing diabetes by 23% over a four year period. ... other classes, and Pfizer's [PFE] Norvasc (amlodipine) remains the leading antihypertensive brand. Norvasc has enjoyed its position as the highest ...

- link to Novartis: Diovan spreads its wings -
Last update: 05/26/2005

Recommended Reading

    Prevacid approval boosts pediatric GERD options. (Proton-Pump Inhibitor).(gastroesophageal reflux disease) : An article from: Family Practice News
    Risperdal - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
    Remicade.(Brief Article) : An article from: Family Practice News
    Amgen falls Ill from Medicare payment shifts. : An article from: Los Angeles Business Journal
    Norvasc - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
    Remicade[R] associated with risks of hepatotoxicity and pneumonia.(PIPELINE PREVIEWS) : An article from: Journal of Drugs in Dermatology
    Hello to All That : A Memoir of War, Zoloft, and Peace
    Evidence-based psychiatric medicine: gabapentin and bipolar disorder.(Adult Psychiatry) : An article from: Clinical Psychiatry News